HUGE News - $TBRIF might see an interesting session as the company’s AI-powered Digital Cough Technology (DCT) is currently being considered as a partner technology for a new innovative, disruptive chronic cough drug US-based clinical trial.
It’s a bug news and may be a big turnaround for $TBRIF. The stock is already in a multi-year breakout.